Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technolo... ( EMERYVILLE Calif. Nov. 28 /- Neur...)

Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.

Date:11/28/2007

EMERYVILLE, Calif., Nov. 28 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc (NTI (TM)) (Nasdaq: NTII) announced today that Warren Wasiewski, M.D. was appointed Chief Medical Officer, effective as of November 26, 2007.

Dr. Wasiewski joined NTI in February 2007 as Vice President, Clinical Programs with primary responsibility for running the clinical trial program for Viprinex(TM), NTI's drug candidate for acute ischemic stroke that is currently in two Phase 3 clinical trials. Dr. Wasiewski is a Board Certified Pediatric Neurologist with an extensive clinical career. Prior to joining NTI, he worked at AstraZeneca where he was Sr. Medical Director of clinical research CNS/Emerging Products. At AstraZeneca, Dr. Wasiewski had responsibility for running the global SAINT trials for AstraZeneca's neuroprotectant drug candidate.

Dr. Wasiewski holds a Bachelor of Arts degree in Biology Cum Laude from Rutgers College, a Masters of Science degree in Biochemistry from State University of New York Downstate Medical Center, and a Doctorate of Medicine from State University of New York, at Buffalo.

About Neurobiological Technologies, Inc.

NTI is a specialty biopharmaceutical company with expertise in identifying and acquiring promising drug candidates and in designing and managing late-stage clinical trials for central nervous system conditions. The Company is currently developing Viprinex(TM) (ancrod), a novel reperfusion agent that is in pivotal Phase 3 trials for the treatment of acute ischemic stroke.

SOURCE Neurobiological Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:11/8/2009)... UCW Academy of Health holds open house at Vict...C (Vocus) November 8, 2009 -- UCW Academy of Healt...ish Columbia’s health care industry to atten...ber 25, 2009. , ,UCW Academy of Health, which off...ing and social services, designs its programs to m...

(Date:11/8/2009)... New book called "Preventing and Healing A...o Giraldo shows that AIDS is a result of multiple,...called immune system stressor agents, which can be...f all, emotional. , Oakl...dash; 8, 2009, cell biologists, physicians, chemis...

(Date:11/8/2009)... 7 Today, the House of ...Dahlkemper, Smith, Ellsworth and Lipinski amendmen...(H.R. 3962). The amendment maintains the current p...nd for benefits packages that include abortion. It...e affordability credits and those who do not, can ...

(Date:11/8/2009)... Passage of H.R. 3961 to Secure the Stability of M...ire/ -- Statement Attributable to: J. James Rohack..., (Logo: http://www.newscom.com/cgi-bin/prnh/...age of the House health reform bill, which will he...icians and calls for swift passage of H.R. 3961 to...

(Date:11/8/2009)...., Nov. 8 March of Dime...uncheon to recognize prominent individuals who are...re role models for March of Dimes commitment to im...of Dimes November Prematurity Awareness Month camp... join the fight for preemies! ,, (Photo: http...

Breaking Medicine News(10 mins):Health News:College Invites Public to Explore Career Options in Health Care 2 Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2 Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3 Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2 Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2 Health News:Hollywood Stars Joined in a Celebration of Babies 2 Health News:Hollywood Stars Joined in a Celebration of Babies 3

[0] College Invites Public to Explore Career Options in Health Care [0] Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor [1] Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill [0] AMA Hails House Passage of Health Reform Bill (H.R. 3962)[0] Hollywood Stars Joined in a Celebration of Babies

...ne, too , , WEDNESDAY, Nov. 5 (HealthDay N...utine task, most people do it without thinking abo...ording to medical experts -- one that could hamper...ng questions, keeping track of what medications th...

... VALENCIA, Calif., Nov. 5 MannKind Corporation,(N...r the third quarter ended,September 30, 2008., Fo...ses were $69.1,million, compared to $75.6 million ...lion for this quarter compared to,$64.8 million fo...

...,Inc. (Nasdaq CM: CRTXD)*, a specialty pharmaceuti...ing prescription medications for respiratory,disor...of the recently,completed merger between Cornersto...ioPharma,s board of directors, has,been appointed ...

...Highlights:, -- Net service revenues increased 84... net revenues rose 113% to $48.6 million -- Net i...PS increased 65% to $0.56 per diluted share on 49%... Family, Inc. (Nasdaq: AFAM ), a leading regional...

...,(Nasdaq: CRGN ), a clinical-stage biopharmaceuti...hat Dr. Timothy M. Shannon, President and Chief,Ex...t the Rodman & Renshaw,Annual Global Investment Co...ss to a live webcast of the presentation will be a...

...re Are Still to be Discovered!, CHERRY HILL, N.J....ed by the Multiple Sclerosis Association of Americ...for anyone interested in giving,back to the commun..."detectives" to locate and report over 60,000,reso...

When It Comes to Prescription Drugs, Get Smart MannKind Corporation Reports Third Quarter Financial Results Cornerstone Therapeutics Announces New Board of Directors Almost Family Reports Third Quarter 2008 Results CuraGen to Present at the Rodman & Renshaw Annual Global Investment Conference Multiple Sclerosis Association of America's Resource Detectives(SM) Program Marks One Year Anniversary

(Date:11/7/2009)...ewswire/ -- Most patients with hereditary angioede...coming HAE attack giving the patients sufficient t...ty associated with that attack, according to surve...llege of Allergy, Asthma & Immunology (ACAAI) ... as fatigue and nausea, which occur frequently bef...

(Date:11/6/2009)...ewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.(&...at is developing and marketing Levulan(®) Pho... on patients with common skin conditions, announce...ficer, will present a corporate overview at the Me..., November 10, 2009 at 10:00 a.m. ET at the Hotel ...

(Date:11/6/2009)...wire-FirstCall/ -- Roper Industries, Inc. (NYSE:...itive agreement to acquire Verathon, Inc., a leadi...erathon Board of Directors has approved the transa...latory approvals and closing conditions, including...sing to be completed in early December. ,, Hea...

Breaking Medicine Technology:Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2 Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3 Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2 Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3 Elsevier to Create New Guidelines for Pharmaceutical Article Reprint Compilation and Custom Publications 48009 1 Elsevier to Create New Guidelines for Pharmaceutical Article Reprint Compilation and Custom Publications 48009 2 Elsevier to Create New Guidelines for Pharmaceutical Article Reprint Compilation and Custom Publications 48009 3 PLC Systems Announces Appointment of Louis Brenner M D to Board of Directors 48005 1 PLC Systems Announces Appointment of Louis Brenner M D to Board of Directors 48005 2 WORLDS First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center 4538 1 WORLDS First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center 4538 2 WORLDS First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center 4538 3

[0] Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity [0] DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009 [0] Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses

... be an essential element of patient assessment, me...ting is often desirable. In keeping with the recen...to easily used point-of-care devices, recent produ...ment of hemoglobin values., ,HemoCue, Inc., La...n Test Systems provide quick, simple and reliable ...

...ry to plan or evaluate anticoagulant therapy, to d...rhomocystinemia, elevated factor VIII levels, dysf... of plasmin generation, and to assess acquired con...ntiphospholipid syndrome, hyperhomocystinemia, amo...long with other tests (such as aspirate aminotrans...

Other Medicine Technology:Hemoglobin Testing at the Point of Care 2 Hemoglobin Testing at the Point of Care 3 Prothrombin Time Comes in Small (CLIA-Waived) Packages 2 Prothrombin Time Comes in Small (CLIA-Waived) Packages 3

Hemoglobin Testing at the Point of Care Prothrombin Time Comes in Small (CLIA-Waived) Packages

AdvancedEMR for Group Practices

ChartKeeper Computerized Medical Records Software

ConnxtMD

...R companies, with a wealth and breadth of experien...f clinical and technical experience, combined with...el training and support, enables PowerMed to trans...to EMR. The unparalleled HL7 and CCR compatible Po...

Medicine Products:

AdvancedEMR for Group Practices ChartKeeper Computerized Medical Records Software ConnxtMD PowerMed Electronic Medical Records (EMR)

Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technolo...( EMERYVILLE Calif. Nov. 28 /- Neur...),Health